Trial Profile
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs Povidone iodine/dexamethasone (Primary) ; Povidone iodine
- Indications Viral-conjunctivitis
- Focus Therapeutic Use
- Sponsors Shire; Shire Human Genetic Therapies; Takeda
- 27 May 2019 Status changed from recruiting to discontinued.
- 24 May 2019 This trial has been discontinued in Hungary, according to European Clinical Trials Database.
- 20 May 2019 This trial has Prematurely Ended in Estonia according to European Clinical Trials Database record.